Trials / Conditions / Solid and Hematological Malignancies
Solid and Hematological Malignancies
4 registered clinical trials studyying Solid and Hematological Malignancies — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Enrolling By Invitation | Long-term Follow-up Study for Participants of Kite-Sponsored Interventional Studies Treated With Gene-Modified NCT05041309 | Kite, A Gilead Company | — |
| Completed | Study to Assess the Effect of Food and Acid Reducing Agents on the Absorption of Capivasertib in Healthy Parti NCT04944771 | AstraZeneca | Phase 1 |
| Terminated | Long Term Follow up of Subjects Exposed to Genetically Engineered T Cell Receptors NCT03391791 | Adaptimmune | — |
| Completed | Screening Protocol for Tumor Antigen Expression Profiling and HLA Typing for Eligibility Determination NCT02636855 | Adaptimmune | — |